TriMetis is a preclinical services company helping medical device, pharmaceutical, and biotech companies and academic institutions advance their research through specialty laboratory and consultation services.
TriMetis operates a 26,000-square-foot Good Laboratory Practice (GLP) facility in Memphis, Tenn., focused on both in vitro and in vivo research. Learn more about the research services that we provide.
In addition to a state-of-the-art laboratory, TriMetis provides access to consulting services and human biospecimen to support your research. Our consultants have extensive expertise in business strategy and development consulting, medical writing, protocol development, quality assurance and training, and project management services. TriMetis is fully compliant with the regulatory requirements of Good Laboratory Practices (GLP), is AAALAC accredited and is in the process of obtaining OLAW accreditation as well.
Our facility is ideal for companies who are:
Seeking rapid study deployment in a Good Laboratory Practice (GLP) environment
Preferring to rent or lease laboratory space over capital investments or improvements
Requiring overflow space for priority studies
Seeking to access to facilities within the continental United States
Based in the land of Elvis, Blues, and BBQ Memphis, TN is becoming home to one of the largest life science developments. Situated in the heart of the downtown Memphis Medical Center which is home to some of the country’s leading hospitals and research centers, including St. Jude Children’s Research Hospital, The University of Tennessee Health Science Center, Methodist Le Bonheur Healthcare, and the Memphis VA Medical Center. TriMetis is able to provide preclinical services, helping medical device, pharmaceutical, and biotech companies and academic institutions advance their research through specialty laboratory services, biospecimen procurement, and consultation services.
Address: 20 South Dudley Street, Suite 806, Memphis, TN, 38103
Who's writing our Story?
Phil Cestaro - President & CEO
Phil has more than 18 years of executive-level experience growing start-ups from foundation to over $65 million in value. He has a proven track record in starting, building, and running companies and divisions, specializing in entrepreneurial leadership, strategic planning, operations, information technology and financial experience.
Prior to joining TriMetis he was the President of SCRI Global Services at Sarah Cannon Research Institute and Director of Life Sciences Product Management and Strategy at Oracle Corporation.
Phil also currently serves as Vice President, Life Sciences with Memphis Bioworks Foundation and works closely with our Memphis, TN clients and partners including University of Tennessee
Phil can be found at our TriMetis headquarters in Memphis, usually running into a meeting or sprinting off to meet with our local clients
Jon Wetzel - COO
Jon is a researcher at heart having over 21 years of experience in the life sciences and 17 years of management in start-up biotech companies. He has created several companies, the latest being a co-founder of FoundationBio, which is now part of TriMetis.
Jon has served in academia and senior roles in industry with; University of Michigan, UCLA, Genelogic, Rosetta Inpharmatics, Asterand and AdeptBio.
While at Asterand Jon developed a successful Biobank that generated significant revenue for the company
Certifications from the University of Michigan for Lean and Six Sigma and is a Certified Six Sigma Black Belt
Jon is on several publications and is the co-inventor on and patent holder of several products.
Jon can be found in the TriMetis lab; setting up biospecimen kits, consulting on collections and lab testing, or more likely balloon twisting, one of his many hobbies!
Leif Honda - SVP Business Development
Leif has over 17 years of experience in the life sciences industry. Prior to joining TriMetis, he co-founded FoundationBio which is now part of TriMetis, as well as successfully built several life science start-ups.
Leif has served in senior roles in several start-up Life Science companies in Research Biospecimen Procurement, Diagnostics, and M&A transactions including companies Digilab, LLC, BioVisioN, GmbH, and Genomic Solutions, LLC.
He is the inventor of several patents in peptide research tools and renal insufficiency diagnostics
He continues to give back to the community through various charities by donating his time and expertise. He is a member of the Board of Visitors of the Kiski School.
Leif can be found at the TriMetis Cambridge, MA location, helping clients further their research, meeting with our ever growing team, or on the soccer field coaching his kids!
Dr. Mandrell is a veterinarian specializing in laboratory animal medicine with over 30 year of experience in academia, government and industry. He is a diplomate of the American College of Laboratory Animal Medicine.
Dr. Mandrell has extensive expertise in the areas of regulatory compliance, biosafety, experimental design, animal model development, pharmacology, analgesia and infectious diseases. He is author or co-author of over 60 published articles, abstracts and book chapters, and has extensive experience as a speaker at national and international meetings.
In addition to his role with TriMetis, he is a consultant for research animal programs in the US and abroad and serves as an Ad Hoc Specialist for the AAALAC.
Dr. Mandrell is a graduate of the University of Tennessee College of Veterinary Medicine and completed a postdoctoral fellowship in Comparative Medicine at the Johns Hopkins University School of Medicine. He recently retired as Director, Professor, and Department Chair University of Tennessee Health Science Center.
Dr. Mandrell serves on the boards of the American College of Laboratory Animal Medicine and the American Association for Laboratory Animal Science.
Outside of his professional work, Dr. Mandrell serves on the board of directors for Service of Self, is an avid tennis player, and also enjoys wing shooting and fly fishing.
Dr. Hamilton has over 10 years of experience in the laboratory animal medicine field and has been a Diplomate of the American College of Laboratory Animal Medicine since 2009. He has expertise in animal diseases, quarantine and health surveillance programs, experimental design, rodent breeding and husbandry, molecular biology, biosafety, and occupational health. He serves at UT Health Science Center as an Associate Professor in the Department of Comparative Medicine. He is a graduate of the Atlantic Veterinary College, Prince Edward Island, Canada and was previous a Companion Animal Veterinarian at the Halifax Veterinary Hospital in Nova Scotia, Canada and a University Veterinarian at McGill University.
Charles Ryan Yates, Pharm.D., Ph.D. is a Professor in the Department of Pharmaceutical Sciences at the University of Tennessee College of Pharmacy and the Ophthalmology Department in the College of Medicine.
His research, which has been funded by the National Institutes of Health, the Food and Drug Administration, Department of Defense, Biomedical Advanced Research and Development Authority (BARDA), and pharmaceutical industry, is focused on the discovery and development of novel anti-inflammatory therapeutics with an emphasis on natural product pharmacophores.
Ryan has over 150 publications (research articles, book chapters, and conference abstracts) and six patents on technologies including genetic testing methods as well as new chemical entities for the treatment of cancer and inflammatory disorders.
Ryan has held various roles with biotech startup companies including VP of Research and Development for RxBio, Inc. where he served as Project Chief for the development of a radiomitigant technology under a contract from BARDA. In addition, he has co-founded several biotech startup companies including Ipax Pharmaceuticals and Seattle Discovery.
20 South Dudley Street, Suite 806
Tel: +1 901 866 1818
1 Broadway, 5th Floor
Tel: +1 (617) 714 9805